Works by JUNG SHIN LEE


Results: 154
    1
    2
    3
    4
    5

    Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR.

    Published in:
    2015
    By:
    • Yoon Ji Choi;
    • Dae Ho Lee;
    • Chang Min Choi;
    • Jung Shin Lee;
    • Seung Jin Lee;
    • Jin-Hee Ahn;
    • Sang-We Kim;
    • Choi, Yoon Ji;
    • Lee, Dae Ho;
    • Choi, Chang Min;
    • Lee, Jung Shin;
    • Lee, Seung Jin;
    • Ahn, Jin-Hee;
    • Kim, Sang-We
    Publication type:
    journal article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Prevalence and risk factors for colonization by extended-spectrum β-lactamase-producing or ST 131 Escherichia coli among asymptomatic adults in community settings in Southern Taiwan.

    Published in:
    Infection & Drug Resistance, 2019, v. 12, p. 1063, doi. 10.2147/IDR.S201086
    By:
    • Wu, Pin-Chieh;
    • Wang, Jiun-Ling;
    • Hsueh, Po-Ren;
    • Lin, Po-Hsiang;
    • Cheng, Ming-Fang;
    • Huang, I-Fei;
    • Chen, Yao-Shen;
    • Lee, Susan Shin-Jung;
    • Guang-Yuan, Mar;
    • Yu, Hsien-Chung;
    • Hsu, Chiao-Lin;
    • Wang, Fu-Wei;
    • Chen, Chi-Shen;
    • Hung, Chih-Hsin;
    • Ko, Wen-Chien
    Publication type:
    Article
    43

    Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).

    Published in:
    Infection & Drug Resistance, 2019, v. 12, p. 627, doi. 10.2147/IDR.S194482
    By:
    • Lai, Chih-Cheng;
    • Chen, Ying-Sheng;
    • Lee, Nan-Yao;
    • Tang, Hung-Jen;
    • Lee, Susan Shin-Jung;
    • Lin, Chin-Fu;
    • Lu, Po-Liang;
    • Wu, Jiunn-Jong;
    • Ko, Wen-Chien;
    • Lee, Wen-Sen;
    • Hsueh, Po-Ren
    Publication type:
    Article
    44

    Antimicrobial activities of ceftazidime–avibactam, ceftolozane–tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016

    Published in:
    Infection & Drug Resistance, 2019, v. 12, p. 545, doi. 10.2147/IDR.S193638
    By:
    • Liao, Chun-Hsing;
    • Lee, Na-Yao;
    • Tang, Hung-Jen;
    • Lee, Susan Shin-Jung;
    • Lin, Chin-Fu;
    • Lu, Po-Liang;
    • Wu, Jiunn-Jong;
    • Ko, Wen-Chien;
    • Lee, Wen-Sen;
    • Hsueh, Po-Ren
    Publication type:
    Article
    45
    46
    47
    48
    49
    50